Bull of the Day: Lumentum (LITE)

$2.0B NVIDIA investment and multiyear purchase commitments announced with Lumentum (and Coherent) to secure advanced lasers, capacity and R&D support. Lumentum is targeting $2.0B in quarterly revenue ($8.0B annualized), expects a Greensboro fab to add ~$5.0B of annual chip-level revenue capacity when it ramps in early 2028, and is aiming for 38%–42% operating margins. Management cited a $400M OCS backlog for H2 and a new hyperscaler OCS agreement that they expect to push OCS to a >$1.0B run rate in 2027; they plan volume shipments of 1.6T transceivers in Q2 and say they are under-shipping demand by ~25%–30%. Analysts have lifted price targets (street-high $1,040), making this outcome strongly positive for LITE and material for the optics/AI infrastructure sector.

Analysis

Lumentum’s moves signal more than a demand-led ramp — they’re reshaping value capture in optical stacks. Turning lasers into turnkey External Light Source (ELS) modules and adding U.S. fab capacity materially increases per-customer revenue content and creates multi-year service/qualification lock-in; that raises gross margin mix and raises switching costs for hyperscalers that lack in-house optics engineering. However, higher revenue per unit also lengthens product lifecycles and O&M exposure (warranty, spares, software), which can compress incremental FCF if not priced into contracts.

The critical second-order supply dynamic is substrate and specialty-material scarcity (InP, substrates, test equipment). These are choke points that favor incumbents who control capacity today and can monetize scarcity via price or prioritized allocation — but they also concentrate execution risk: a delayed fab ramp or yield shortfall converts a multi-year upside into a 30–50% downside in market expectations within 6–12 months. Geopolitical and export-control shocks (China cross-flows, equipment restrictions) would amplify that asymmetry.

Catalysts and timelines: near-term (next 1–3 quarters) expect backlog recognition and order cadence data points; medium-term (9–18 months) is where margin expansion and ELS attach rates should manifest in results; long-term (2027–2029) is when new fab capacity could either unlock the $5B revenue ceiling or create temporary oversupply that re-prices multiples. The consensus is bullish on TAM growth but underappreciates the capital and yield-execution cliff — earnings multiple expansion is contingent on sustained high mix and contract terms that lock in price and volume beyond simple spot demand.

Key Decisions for Investors

• Long LITE equity (size 2–4% NAV): accumulate on pullbacks of 20–30% from recent highs, target 12-month upside of 30–50% if ELS attach and margin guidance materialize; hard stop at a 25% drawdown or if management delays fab ramp guidance by >6 months.
• Directional option spread — LITE Dec-2026 3:1 call-spread structure (buy OTM call / sell higher OTM call) sized to risk <5% NAV: asymmetric payout captures upside from 2027 capacity and margin expansion while capping premium loss; target 3x+ payoff if guidance path holds.
• Pair trade for conviction differential: long LITE / short COHR (net delta-neutral, size 1–2% NAV each): LITE favored for turnkey ELS and U.S. fab tie-up while COHR is more exposed to commoditization risk. Time horizon 9–18 months; expect relative outperformance >20% if LITE execution is clean.
• Event hedge: buy LITE 3–6 month puts (or put spread) ahead of quarterly prints if position is >2% NAV — protects against a fast re-rating from execution misses or customer destocking; treat as insurance, cost target 1–2% NAV for protection against a 30–40% sell-off.
• Monitor supply-chain indicators weekly (InP wafer lead times, test-tool orders, fab hiring rates) and set an alert to trim longs if InP lead times lengthen or if large hyperscalers disclose internal optics development — these are 60–180 day reversal signals.